These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3938733)

  • 1. Plasma concentration of prolactin during four-day osmotic pump infusion of thyrotropin-releasing hormone and vasoactive intestinal polypeptide in rats.
    Niimi M; Takahara J; Kawanishi K
    Endocrinol Jpn; 1985 Dec; 32(6):929-32. PubMed ID: 3938733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study on the prolactin releasing mechanism using an in vitro perfusion system with a cell column of cultured rat anterior pituitary cells].
    Kageyama J
    Nihon Naibunpi Gakkai Zasshi; 1984 Oct; 60(10):1243-54. PubMed ID: 6440813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a synergistic effect of somatostatin on vasoactive intestinal polypeptide-induced prolactin release in the rat: comparison with its effect on thyrotropin (TSH)-releasing hormone-stimulated TSH release.
    Michalkiewicz M; Suzuki M; Kato M
    Endocrinology; 1987 Jul; 121(1):371-7. PubMed ID: 2885177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of dopamine antagonists and/or VIP on TRH- or VIP-induced prolactin release in estrogen- and progesterone-treated ovariectomized rats.
    Haisenleder DJ; Moy JA; Gala RR; Lawson DM
    Proc Soc Exp Biol Med; 1988 Mar; 187(3):341-9. PubMed ID: 3126503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone induced prolactin release.
    Balsa JA; Cacicedo L; Lara JI; Lorenzo MJ; Pazos F; Sanchez-Franco F
    Endocrinology; 1996 Jan; 137(1):144-50. PubMed ID: 8536606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal interactions of somatostatin with thyrotropin-releasing hormone and vasoactive intestinal peptide on prolactin and growth hormone secretion in vitro.
    Enjalbert A; Epelbaum J; Arancibia S; Tapia-Arancibia L; Bluet-Pajot MT; Kordon C
    Endocrinology; 1982 Jul; 111(1):42-7. PubMed ID: 6123432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of VIP, TRH, GABA and dopamine on prolactin release from superfused rat anterior pituitary cells.
    Matsushita N; Kato Y; Shimatsu A; Katakami H; Yanaihara N; Imura H
    Life Sci; 1983 Mar; 32(11):1263-9. PubMed ID: 6132313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contradictory clinical implications between paradoxical growth hormone responses to thyrotropin-releasing hormone and those to vasoactive intestinal peptide and luteinizing hormone-releasing hormone in acromegaly.
    Watanobe H; Tamura T; Sasaki S; Takebe K
    Neuropeptides; 1993 Dec; 25(6):363-75. PubMed ID: 8127416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal polypeptide and thyrotropin-releasing hormone stimulate newly synthesized, not stored, prolactin.
    Maas DL; Arnaout MA; Martinson DR; Erdmann MD; Hagen TC
    Endocrinology; 1991 Feb; 128(2):1015-20. PubMed ID: 1899215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VIP enhances TRH-stimulated prolactin secretion of pituitary tumours. Studies with 31P NMR.
    Prysor-Jones RA; Silverlight JJ; Jenkins JS; Stevens AN; Rodrigues JL; Griffiths JR
    FEBS Lett; 1984 Nov; 177(1):71-5. PubMed ID: 6437866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of vasoactive intestinal peptide and 5-HT2 receptor subtype in serotonin stimulation of basal and thyrotropin-releasing-hormone-induced prolactin release in vitro from rat pituitary cells.
    Apfelbaum ME
    Neuroendocrinology; 1998 Jan; 67(1):45-50. PubMed ID: 9485168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of thyrotropin-releasing hormone, vasoactive intestinal peptide, phorbol ester, and depolarization in GH4C1 rat pituitary cells.
    Aizawa T; Hinkle PM
    Endocrinology; 1985 Mar; 116(3):909-19. PubMed ID: 3918848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitonin inhibits basal and thyrotropin-releasing hormone-induced release of prolactin from anterior pituitary cells: evidence for a selective action exerted proximal to secretagogue-induced increases in cytosolic Ca2+.
    Shah GV; Wang W; Grosvenor CE; Crowley WR
    Endocrinology; 1990 Aug; 127(2):621-8. PubMed ID: 2115431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of transient dopamine antagonism on thyrotropin-releasing hormone-induced prolactin release in pseudopregnant rats.
    Haisenleder DJ; Moy JA; Gala RR; Lawson DM
    Endocrinology; 1986 Nov; 119(5):1989-95. PubMed ID: 3095097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of dopaminergic antagonism by sulpiride on TRH and VIP-induced prolactin release in nonsuckled lactating rats.
    Haisenleder DJ; Moy JA; Lawson DM
    Life Sci; 1990; 46(25):1867-72. PubMed ID: 2163481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological roles of thyrotrophin-releasing hormone and vasoactive intestinal peptide on the pulsatile secretory patterns of prolactin in pituitary-grafted female rats.
    Lafuente A; Marcó J; Esquifino AI
    J Endocrinol; 1994 Sep; 142(3):581-6. PubMed ID: 7964307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different prolactin, thyrotropin, and thyroxine responses after prolonged intermittent or continuous infusions of thyrotropin-releasing hormone in rhesus monkeys.
    Pavasuthipaisit K; Norman RL; Ellinwood WE; Oyama TT; Baughman WL; Spies HG
    J Clin Endocrinol Metab; 1983 Mar; 56(3):541-8. PubMed ID: 6401761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary vasoactive intestinal peptide regulates prolactin secretion in the hypothyroid rat.
    Lam KS; Reichlin S
    Neuroendocrinology; 1989 Nov; 50(5):524-8. PubMed ID: 2514393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
    Christian HC; Chapman LP; Morris JF
    J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin responses to vasoactive intestinal polypeptide and thyrotropin releasing hormone in chronic renal failure.
    Arnaout MA; Hamzeh YS; Ajlouni KM
    Acta Endocrinol (Copenh); 1991 Dec; 125(6):651-6. PubMed ID: 1789061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.